AKT1 and glioblastoma: Genomic alterations such as amplification of EGFR gene or mutation and methylation of PTEN tumor suppressor gene have been observed in 50–70% of glioblastoma cases and correlate with the deregulation of the PI3K/Akt pathway [153,154].